Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. 2004

Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
Institut de Sciences Cognitives, Bron, France.

Attentional and executive impairments have been found both in patients with schizophrenia and in their unaffected first-degree relatives, suggesting that they might be considered as familial vulnerability markers. Several studies have shown that the performance of bipolar patients does not significantly differ from that of schizophrenic patients, so that executive and attentional deficits might not be specific to schizophrenia. In the present study, we aimed to identify executive dysfunctions in schizophrenia and bipolar disorder that might be vulnerability trait markers specific to one or common to both of these diseases. We assessed cognitive performance of euthymic bipolar and schizophrenic patients, their unaffected first-degree relatives and a healthy control group, using neuropsychological tasks to test different components of executive function: the Verbal Fluency Test, the Stroop Word Colour Test, the Wisconsin Card Sorting Test and the Trail Making Test. The two groups of patients and their unaffected relatives demonstrated disproportionately increased slowness on the Stroop test in comparison to the normal healthy group. Patients with schizophrenia performed poorly on all the tests in comparison to the normal healthy subjects, while no other impairment was observed in the bipolar patients and in the relatives of schizophrenic and bipolar patients. Enhanced susceptibility to interference and reduced inhibition could be transnosographical markers for a shared familial vulnerability common to schizophrenia and bipolar disorders.

UI MeSH Term Description Entries
D008297 Male Males
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011594 Psychometrics Assessment of psychological variables by the application of mathematical procedures. Psychometric
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
November 2013, Journal of psychiatric research,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
February 1997, Schizophrenia research,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
September 2014, European archives of psychiatry and clinical neuroscience,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
January 2017, Journal of the American Academy of Child and Adolescent Psychiatry,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
July 1992, Annals of the New York Academy of Sciences,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
March 2012, Genetics in medicine : official journal of the American College of Medical Genetics,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
September 2008, Schizophrenia research,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
February 2000, Biological psychiatry,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
April 2016, Psychiatry research,
Tiziana Zalla, and Cécile Joyce, and Andrei Szöke, and Franck Schürhoff, and Bernard Pillon, and Odile Komano, and Fernando Perez-Diaz, and Frank Bellivier, and Caroline Alter, and Bruno Dubois, and Frédéric Rouillon, and Olivier Houde, and Marion Leboyer
August 2004, European archives of psychiatry and clinical neuroscience,
Copied contents to your clipboard!